Post-operative Analgesic Effect of Oral Nefopam (NefPO)

  • STATUS
    Recruiting
  • End date
    Nov 15, 2023
  • participants needed
    58
  • sponsor
    Hospices Civils de Lyon
Updated on 23 March 2022

Summary

High tibial osteotomy is a common procedure in orthopedic surgery; it is highly standardized (incision location and size, the volume of periosteal lesion, implanted material). It is associated with short recovery period but intense postoperative pain during first 24 hours. The surgical wound has a comprehensive innervation by saphenous and a terminal muscular branches of tibial nerve. These conditions allow reproducible measurements of analgesic drugs effects in postoperative period.

Nefopam is a non-opioid centrally acting analgesic drug used as a part of multimodal analgesia. The opioid-sparing effect of nefopam is still controversial across various surgical procedures. In France nefopam is only available as a parenteral formulation; however it is often administered orally. There is currently no study addressing the efficacy of oral nefopam for the postoperative pain management including pain prevention.

The investigators conduct a prospective, double-blinded randomized controlled study with the main objective to examine the effect of perioperative orally administered nefopam on postoperative pain after a high tibial osteotomy. Secondary objectives include the quantification of wound allodynia, analysis of adverse events, clinical outcomes, and a pharmacokinetic study of orally given nefopam (plasma and cerebrospinal fluid dosage).

Details
Condition Postoperative Pain After a High Tibial Osteotomy
Treatment Placebo, Oral nefopam
Clinical Study IdentifierNCT04576078
SponsorHospices Civils de Lyon
Last Modified on23 March 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

adult patients scheduled for a high tibial osteotomy under spinal anesthesia at the Hopital de la Croix Rousse, Hospice Civils de Lyon, France
ASA (American Society of Anesthesiology) class between 1 et 3
written informed consent

Exclusion Criteria

any contraindication for nefopam (known hypersensitivity, past medical history of seizures, urinary retention, benign prostate hyperplasia, angle glaucoma, ischemic cardiomyopathy waiting for revascularization, atrial fibrillation)
medical conditions known to influence the pharmacokinetics of nefopam (chronic kidney failure with Glomerular Filtration Rate (GFR) <30mL/min/1,73m2, liver failure, current treatment with rifampicin, carbamazepine, azoles fungicides, macrolides)
current treatment with benzodiazepines, anxiolytics, antidepressants, histamine H1 antagonists, neuroleptics, baclofen, thalidomide, barbiturates
medical history of gastric or esophageal surgery
phenylketonuria
pregnancy or breastfeeding
past use of oral nefopam
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note